Humacyte Inc

General ticker "HUMA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $509.2M

Humacyte Inc follows the US Stock Market performance with the rate: 31.9%.

Estimated limits based on current volatility of 14.5%: low 3.87$, high 5.18$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.82$, 4.40$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.14$, 4.91$]

Financial Metrics affecting the HUMA estimates:

  • Negative: Non-GAAP EPS, $ of -0.93 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -20.30 <= 2.35
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term HUMA quotes

Long-term HUMA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.26MM $1.56MM $0.00MM
Operating Expenses $82.47MM $86.14MM $100.05MM
Operating Income $-81.21MM $-84.58MM $-100.05MM
Non-Operating Income $54.73MM $72.61MM $-10.73MM
Interest Expense $4.35MM $6.20MM $1.13MM
R&D Expense $61.34MM $63.26MM $76.55MM
Income(Loss) $-26.48MM $-11.96MM $-110.78MM
Profit(Loss) $-26.48MM $-11.96MM $-110.78MM
Stockholders Equity $122.17MM $116.93MM $13.55MM
Inventory $0.00MM $0.03MM $0.00MM
Assets $286.53MM $204.30MM $128.22MM
Operating Cash Flow $-81.19MM $-71.13MM $-73.31MM
Capital expenditure $0.22MM $1.05MM $2.28MM
Investing Cash Flow $-8.22MM $4.84MM $-0.17MM
Financing Cash Flow $266.98MM $-1.45MM $4.51MM
Earnings Per Share* $-0.94 $-0.62 $-1.07

* EPS are Split Adjusted, recent splits may be reflected with a delay.